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Abstract In this report, the role of phosphorylation in the
regulation of ubiquitination and turnover of the ABC-transport-
er Ste6 was investigated. We demonstrate that Ste6 is phosphor-
ylated in vivo and that this phosphorylation is dependent on the
presence of an acidic stretch (‘A-box’) in the linker region pre-
viously shown to be important for ubiquitination and fast turn-
over of Ste6. By mutagenesis, two serine/threonine residues were
identi¢ed in the A-box region that are crucial for ubiquitination
and tra⁄cking to the yeast vacuole. In the mutants there was no
simple correlation between phosphorylation and ubiquitination
levels, suggesting that the two events may not be coupled.
* 2002 Published by Elsevier Science B.V. on behalf of the
Federation of European Biochemical Societies.
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1. Introduction
Information about substrate features that specify recogni-
tion by the ubiquitination machinery is still limited. The
N-terminal amino acid has been recognized as a feature which
may specify the half-life of a protein (‘N-end rule’) [1]. Other
sequence motifs shown to be important for ubiquitin-medi-
ated degradation are the cyclin destruction box, ¢rst identi¢ed
in mitotic cyclins [2] and stretches rich in Pro, Glu/Asp, Ser
and Thr residues, so-called ‘PEST-regions’ [3,4]. Another
ubiquitination signal is contained in the K-factor receptor
Ste2. It could be shown that the nine amino acid sequence
SINNDAKSS, which is required for the endocytosis of the
liganded receptor [5], serves as an attachment site for ubiqui-
tin [6]. Ubiquitination at the SINNDAKSS sequence appears
to be regulated by phosphorylation [7].
We are interested in identifying the signals that mediate
ubiquitination and rapid turnover of the ABC-transporter
Ste6. Ste6 accumulates at the plasma membrane in a ubiquiti-
nated form upon block of endocytosis [8]. This ubiquitination
is mediated by a signal contained in the 100-amino acid long
linker region (‘D-box’ for degradation box) which connects
the two homologous halves of Ste6 [9]. A Ste6 mutant where
part of the D-box is deleted (‘A-box deletion’) is no longer
ubiquitinated and strongly stabilized. In this report, we inves-
tigated whether Ste6 ubiquitination is regulated by phosphor-
ylation. We found that Ste6 is indeed phosphorylated, as
reported previously [10] and that this phosphorylation is
abolished by the A-box deletion. To identify the phosphory-
lation sites in the A-box region, we mutagenized potential
target sites for serine/threonine phosphorylation. Two serine/
threonine exchanges were identi¢ed which in combination led
to a stabilization and a reduction in ubiquitination compara-
ble to the A-box deletion. However, there was no clear-cut
correlation between the degree of phosphorylation and ubiq-
uitination, suggesting that these two events may not be
coupled.
2. Materials and methods
2.1. Strains, plasmids and growth conditions
The Saccharomyces cerevisiae strain used for all experiments was
RKY959 MATa his3-v200 leu2-3,112 lys2-801 vste6: :LEU2 trp1-v63
ura3-52. The parent single-copy plasmid was pRK278, which contains
a 6.2 kb BglII/SalI chromosomal STE6 fragment cloned into the
centromer vector YCplac33 [11] (with deleted PstI site). As parent
2W-vector the plasmid pYKS2 was used, which is derived from
YEp352 and contains a c-myc-tagged STE6 gene [10]. Plasmid
pRK182 contains the same STE6 fragment as pRK278 cloned into
the centromer plasmid YCp50 [12]. The cells were grown in SD-me-
dium with 1% casamino acids [13]. HA-tagged ubiquitin was ex-
pressed from the 2W-plasmid YEp112 [14] under the control of the
CUP1 promoter by the addition of 0.5 mM CuSO4 for 30 min before
extract preparation.
2.2. Construction of mutants
Site-directed mutagenesis was performed with the Bio-Rad Muta-
Gene1 kit based on the method of Kunkel et al. [15]. A 1.2 kb
internal PstI STE6 fragment (pos. 1620^2830), cloned into the phag-
emid pUC218, was mutagenized with the following mutagenic primers
(exchanges marked in bold print). T613A (primer #98): 5P-G
(pos. 2283) AATGACTACTCTGATGCGAAAGCGATCGTAGA-
TACAGAGACTGAAG (new PvuI site); S623L (primer #114):
5P-A (pos. 2317) CAGAGACTGAAGAAAAGCTTATACACACTG-
TGGAAAG (new HindIII site). All mutations were con¢rmed by
sequencing.
2.3. In vivo labeling of cells and immunoprecipitation
For the phosphorylation experiments, cells were grown overnight in
SD-low phosphate medium [16] (30 WM KH2PO4) to an A6009 0.8
(4U107 cells/ml). 5U107 cells were labeled with 200 WCi
[32P]orthophosphate (Amersham, PBS11) for 30 min at 30‡C in 0.5
ml of SD-low phosphate medium. The cells were washed in 10 mM
NaN3, resuspended in 110 Wl lysis-bu¡er (50 mM HEPES, 0.3 M
sorbitol, 10 mM NaN3, pH 7.5+ protease inhibitor cocktail and 50
Wg/ml RNase A) and vortexed for 3 min with 400 mg of glass beads.
Ste6 was immunoprecipitated from the cell extracts and analyzed by
SDS^PAGE and autoradiography as described previously [8]. X-ray
¢lms (Kodak) were exposed for about 5 h for 2W-STE6 and 3 days for
single-copy STE6. Pulse-chase experiments were performed as de-
scribed previously [8].
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2.4. Immuno£uorescence experiments
Immuno£uorescence experiments were performed as described in
[17].
3. Results
3.1. A-box dependent phosphorylation of Ste6
To test for Ste6 phosphorylation, cells of the STE6 deletion
strain RKY959, transformed with a multicopy STE6 plasmid
or with a vector control, were labeled with [32P]orthophos-
phate. As can be seen in Fig. 1B (lane 3), a strong phosphor-
ylation signal could be detected for wild-type Ste6 while no
signal was detected with the vector control (Fig. 1B, lane 1).
Phosphorylation of Ste6 has also been demonstrated previ-
ously [10]. We then examined the phosphorylation status of
the Ste6 vA-box variant which is defective in ubiquitination
and strongly stabilized but fully functional in a-factor secre-
tion and mating [9]. With this A-box deletion variant no phos-
phorylation signal could be detected (Fig. 1B, lane 2). The
Western blot control in Fig. 1A shows that the vA-box pro-
tein is expressed under these conditions. The concurrent loss
of phosphorylation and ubiquitination in the A-box mutant
points to a role of phosphorylation in Ste6 turnover.
3.2. Potential targets for serine/threonine phosphorylation in
the A-box region
In our search for potential phosphorylation sites, we fo-
cused on serine/threonine residues contained in two short se-
quence motifs resembling the ‘DAKSS’ motif, found in the
K-factor receptor Ste2, which acts as a phosphorylation and
ubiquitination signal [7] and is required for e⁄cient Ste2 en-
docytosis [5]. To assess the contribution of these residues to
phosphorylation and turnover of Ste6, mutants were con-
structed by site-directed mutagenesis. Threonine 613 in the
DAKTI sequence was replaced by alanine (T613A), serine
623 was replaced by leucine (S623L). Furthermore, a double
mutant was constructed (T613A S623L). The stability of these
mutants was determined by pulse-chase experiments. As can
be seen in Fig. 2, both the T613A mutation (Fig. 2B, d=45
min) and the S623L mutation (Fig. 2C, d=80 min) stabilize
Ste6 about two- to three-fold. The stabilizing e¡ects were
additive. When the two mutations were combined, a ¢ve-
fold stabilization comparable to that of the A-box deletion
was observed (Fig. 2D, d=110 min). The half-life of wild-
type Ste6 in this strain background was about 25 min (Fig.
2A). A quanti¢cation of the results is presented in Fig. 2E.
To exclude that the observed stabilization is caused by mis-
folding of the proteins and degradation by a slower alterna-
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Fig. 1. A-box dependent phosphorylation of Ste6. Cells of the STE6
deletion strain RKY959, transformed with di¡erent STE6 plasmids,
were labeled with [32P]orthophosphate: (1) YEplac195 (vector), (2)
pRK264 (vA-box), (3) pYKS2 (wild-type STE6). A: Western blot
of the cell extracts with anti-Ste6 antibodies. B: Autoradiogram of
the proteins immunoprecipitated with anti-Ste6 antibodies.
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Fig. 2. Pulse-chase experiment: stability of Ste6 variants. Cells of
the STE6 deletion strain RKY959, transformed with di¡erent single
copy STE6 plasmids, were labeled with [35S]methionine for 15 min
and were then chased with an excess of cold methionine. Ste6 was
immunoprecipitated from cell extracts prepared at time intervals, as
indicated. The precipitated proteins were analyzed by SDS^PAGE
and autoradiography. Plasmids used were: A: pRK182 (wild-type
STE6) ; B: pRK321 (T613A); C: pRK402 (S623L); D: pRK337
(T613A S623L); E: Quanti¢cation of Ste6 signals. A background
band unrelated to Ste6 is marked by an asterisk.
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tive pathway, the mating activity mediated by the Ste6 var-
iants was determined by a patch mating assay. The Ste6 mu-
tants displayed a mating activity indistinguishable from wild
type (data not shown). Therefore, the mutations appear to
speci¢cally a¡ect the normal degradation pathway of Ste6.
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Fig. 3. Ubiquitination of Ste6 variants. RKY959 was transformed
with YEp112, expressing HA-tagged ubiquitin, and with 2W-plas-
mids, expressing di¡erent Ste6 variants. The plasmids were: (1) YE-
plac195 (vector), (2) pRK264 (vA-box), (3) pRK322 (T613A), (4)
pRK427 (S623L), (5) pRK339 (T613A S623L), (6) pYKS2 (wt
STE6). Proteins immunoprecipitated with Ste6 antibodies were ana-
lyzed by Western blotting with the anti-HA antibody, to detect
ubiquitin (A) and with anti-Ste6 antibodies to detect Ste6 (B). Back-
ground bands from immunoprecipitation (IgG, protein A) are
marked by asterisks. The position of Ste6 is indicated by an arrow.
C: Detection of HA-ubiquitin in cell extracts by Western blotting
with HA-antibodies.
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Fig. 4. Localization of Ste6 variants by immuno£uorescence. Detec-
tion of c-myc-tagged Ste6 variants, expressed in strain RKY959,
with anti-myc primary antibodies and DTAF-conjugated anti-mouse
secondary antibodies. A: pYKS2 (wt STE6); B: pRK322 (T613A);
C: pRK427 (S623L); D: pRK339 (T613A S623L); E: pRK264
(vA-box). Left panels: DTAF-staining; right panels: phase contrast
image.
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3.3. Modi¢cation and localization of the Ste6 variants
To determine the degree of ubiquitination of the di¡erent
Ste6 variants, Ste6 protein immunoprecipitated from cell ex-
tracts was assayed for the presence of covalently attached
HA-tagged ubiquitin. Ubiquitination of Ste6 was detected as
a ‘ubiquitin-smear’ on the upper part of the gel. A strong
ubiquitination signal was observed for wild-type Ste6 (Fig.
3A, lane 6) while no signal was detectable with the vA-box
variant (Fig. 3A, lane 2), as reported previously [9]. The
T613A mutant showed a reduced level of ubiquitination
(Fig. 3A, lane 3) which was further reduced by the introduc-
tion of the S623L mutation (Fig. 3A, lane 5). But in contrast
to the vA-box variant there was still some residual ubiquiti-
nation visible. Surprisingly, however, the S623L mutant alone
did not show a detectable ubiquitination defect. As a control,
the immunoprecipitates were probed with anti-Ste6 antibodies
by Western blotting (Fig. 3B), demonstrating that comparable
amounts of Ste6 protein had been precipitated. Furthermore,
care had been taken to achieve comparable levels of expres-
sion of HA-tagged ubiquitin (Fig. 3C).
The intracellular localization of the Ste6 variants was de-
termined by immuno£uorescence experiments (Fig. 4). Wild-
type Ste6 exhibited a mostly intracellular, patchy staining
(Fig. 4A). Patches were often seen associated with the vacuole
which can be seen as white spots in the phase contrast image.
With the T613A mutant, which also showed reduced ubiqui-
tination, a bright cell surface staining was observed in addi-
tion to the intracellular signal (Fig. 4B). This indicates, as
suggested previously [9], that ubiquitination may be involved
in internalization of the Ste6 protein. The S623L mutant,
however, showed a very di¡erent staining pattern (Fig. 4C).
With this mutant, a perivacuolar staining was observed in
many cells in addition to some cell surface staining, which
was not as pronounced as in the T613A mutant. The ring-
like staining around the vacuole points to a defect in sorting
to the multi-vesicular-bodies (MVB) pathway [18,19]. The
double mutant T613A S623L had a staining similar to the
T613A mutant (Fig. 4D), i.e. the T613A mutation appears
to be ‘dominant’ over the S623L mutation. This could indicate
that the DAKTI signal acts before the EEKSI signal in a
sequential pathway. The vA-box mutant was included for
comparison (Fig. 4E).
We then examined whether the observed e¡ects on ubiqui-
tination and turnover are correlated with a reduction in Ste6
phosphorylation. Again, no phosphorylation signal could be
detected for the vA-box deletion (Fig. 5A, lane 2). However,
with the other mutants no clear-cut correlation between the
e¡ects on ubiquitination and turnover and phosphorylation
could be established. Phosphorylation was not a¡ected by
the T613A mutation despite its marked e¡ect on ubiquitina-
tion and turnover (Fig. 5A, lane 3). In contrast, phosphory-
lation was reduced for the S623L variant (Fig. 5A, lane 4),
which displays a wild-type ubiquitination level. The T613A
S623L double mutant had a somewhat lower phosphorylation
level than the S623L single mutant (Fig. 5A, lane 5).
4. Discussion
In this report, we demonstrate that Ste6 phosphorylation is
dependent on the presence of a 50 amino acid stretch in the
linker region (‘A-box’) connecting the two homologous halves
of Ste6. In our attempt to localize the phosphorylation site(s)
within the A-box region, we focused on two short sequence
stretches (‘DAKTI’ and ‘EEKSI’) resembling a sequence mo-
tif (‘DAKSS’) shown to be required for endocytosis of the
K-factor receptor Ste2 [5]. Mutation of the serine/threonine
residues in the two DAKSS-like sequences resulted in a stabi-
lization of Ste6. The stabilizing e¡ects of the single exchanges
were additive. When the two mutations were combined
(T613A S623L) the observed stabilization was about as strong
as that of the whole A-box deletion. This shows that the turn-
over signal, present in the A-box region, can be inactivated by
two single point mutations. Although both single point muta-
tions stabilized Ste6 to a similar extent, the phenotype of these
mutations was di¡erent. The T613A mutation in the DAKTI
sequence resulted in reduced ubiquitination and in accumula-
tion of Ste6 at the plasma membrane. This is in line with the
proposed role of ubiquitination in endocytosis of yeast plasma
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Fig. 5. Phosphorylation of Ste6 variants. RKY959, transformed
with di¡erent 2W STE6 plasmids, was labeled with [32P]ortho-
phosphate. A: Autoradiogram of the proteins immunoprecipitated
with anti-Ste6 antibodies. Ste6 is marked by an arrow. B: Western
blot of corresponding cell extracts with anti-Ste6 antibodies. (1)
YEplac195 (vector), (2) pRK264 (vA-box), (3) pRK322 (T613A),
(4) pRK427 (S623L), (5) pRK339 (T613A S623L), (6) pYKS2
(wt STE6) ; lane 7 in (A) [35S]methionine-labeled Ste6.
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membrane proteins [20]. From this result, it can be concluded
that the DAKTI motif is required for the ubiquitination and
internalization of Ste6, as suggested previously [9]. In the
EEKSI motif mutant, however, ubiquitination was normal
and the mutant protein was mainly found internal around
the vacuole. The most likely explanation for this ¢nding is
that the EEKSI motif a¡ects another, presumably internal,
tra⁄cking step, which could be sorting of Ste6 to the MVB
pathway [18,19].
The T613A S623L double mutant showed a Ste6 immuno-
£uorescence staining pattern very similar to the T613A single
mutant. The T613A mutation, therefore, appears to be ‘dom-
inant’ over the S623L mutation, at least with respect to im-
muno£uorescence staining. This can be taken as an indication
that the tra⁄cking step a¡ected by T613A lies before the
S623L-dependent step. The ubiquitination defect of the dou-
ble mutant, however, was much more severe than in the
T613A single mutant. The reason for that could be that the
S623L mutation not only inactivates the EEKSI motif but
also further impairs recognition of the mutated DAKTI motif
by the ubiquitination machinery through a change in the sec-
ondary structure around the DAKTI sequence.
Although the examined mutations had profound e¡ects on
Ste6 turnover, there was no simple correlation between the
phosphorylation state of Ste6 and its ubiquitination. In the
case of T613A, ubiquitination was reduced while phosphory-
lation was normal. The opposite e¡ect was seen with the
S623L mutant. Here, phosphorylation was reduced and ubiq-
uitination was normal. The most likely explanation for these
¢ndings is that the serine/threonine mutations do not act
through the inactivation of speci¢c phosphorylation sites.
Where then are the phosphorylation site(s) and what is their
function? Phosphorylation may occur at other serine/threo-
nine residues in the A-box region. These residues may not
directly be part of the turnover signal(s) but could regulate
their availability to the ubiquitination machinery. In any case,
the data presented for Ste6 cannot be easily reconciled with
the idea that phosphorylation is a prerequisite for ubiquitina-
tion, as proposed for other yeast plasma membrane proteins
[7,21].
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